Barclays Reiterates Overweight Rating on Bruker Corporation (BRKR)

Market Context

Bruker Corporation operates in the Healthcare sector. The stock currently trades at $58.44 with a market capitalization of $7.0B. The stock has gained 53.5% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Bruker Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Bruker Corporation

Among the 10 most recent ratings: 7 Buy, 3 Hold, 0 Sell.

Related Tools: Analyst Ratings Dashboard | View BRKR Stock Page